Purported Investor Class Action Settled By Theranos, 2 Corporate Officers
SAN JOSE, Calif. — Beleaguered blood-testing startup Theranos Inc. and its two former officers on July 20 stipulated to dismissal of an investor class action without disclosing terms (Robert Colman, et...To view the full article, register now.
Already a subscriber? Click here to view full article